Insider Trading activities of Denali Therapeutics Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Denali Therapeutics Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Denali Therapeutics Inc. since year 2005. Table 2 shows the detailed insider transactions of Denali Therapeutics Inc. since 2005. The reporting company's ticker symbol is DNLI. The reporting company's CIK number is 1714899.
The total value of stock buying since 2005 is $4,950,000.
The total value of stock sales since 2005 is $5,190,338.
The total value of stock option exercises since 2005 is $237,953.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Denali Therapeutics Inc. (DNLI).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2019-02 0 $0 43,334 $815,197 17,500 $92,399
2019-01 0 $0 40,335 $793,208 11,725 $61,908
2018-12 0 $0 43,333 $826,388 0 $0
2018-11 0 $0 35,834 $647,824 0 $0
2018-10 0 $0 35,833 $778,292 7,043 $52,399
2018-09 0 $0 35,833 $682,801 0 $0
2018-08 0 $0 35,834 $646,628 0 $0
2018-06 0 $0 0 $0 5,918 $31,247
2017-12 275,000 $4,950,000 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Denali Therapeutics Inc. insiders (DNLI)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2019-02-12 Schuth Alexander O. (COO and Secretary) Sale 2,500 19.98 49,962
2019-02-11 Schuth Alexander O. (COO and Secretary) Sale 2,500 19.05 47,612
2019-02-08 Schuth Alexander O. (COO and Secretary) Sale 2,500 18.11 45,275
2019-02-05 Ho Carole (Chief Medical Officer) Sale 7,856 18.83 147,928
2019-02-05 Ho Carole (Chief Medical Officer) Option Ex 7,856 5.28 41,479
2019-02-05 Watts Ryan J. (President and CEO) Sale 8,230 18.83 154,970
2019-02-04 Ho Carole (Chief Medical Officer) Sale 3,869 18.80 72,737
2019-02-04 Ho Carole (Chief Medical Officer) Option Ex 3,869 5.28 20,428
2019-02-04 Watts Ryan J. (President and CEO) Sale 4,054 18.80 76,235
2019-02-01 Ho Carole (Chief Medical Officer) Sale 5,775 18.64 107,646
2019-02-01 Ho Carole (Chief Medical Officer) Option Ex 5,775 5.28 30,492
2019-02-01 Watts Ryan J. (President and CEO) Sale 6,050 18.65 112,832
2019-01-11 Schuth Alexander O. (COO and Secretary) Sale 2,500 20.80 52,000
2019-01-10 Schuth Alexander O. (COO and Secretary) Sale 2,500 19.99 49,974
2019-01-09 Schuth Alexander O. (COO and Secretary) Sale 2,500 20.31 50,775
2019-01-04 Ho Carole (Chief Medical Officer) Sale 5,950 19.66 117,006
2019-01-04 Ho Carole (Chief Medical Officer) Option Ex 5,950 5.28 31,416
2019-01-04 Watts Ryan J. (President and CEO) Sale 6,233 19.60 122,166
2019-01-03 Ho Carole (Chief Medical Officer) Sale 2,777 18.90 52,485
2019-01-03 Ho Carole (Chief Medical Officer) Option Ex 5,775 5.28 30,492
2019-01-03 Watts Ryan J. (President and CEO) Sale 6,050 18.89 114,284
2019-01-02 Ho Carole (Chief Medical Officer) Sale 5,775 19.84 114,547
2019-01-02 Watts Ryan J. (President and CEO) Sale 6,050 19.83 119,971
2018-12-12 Schuth Alexander O. (COO and Secretary) Sale 2,500 20.80 52,000
2018-12-11 Schuth Alexander O. (COO and Secretary) Sale 2,500 20.22 50,550
2018-12-10 Schuth Alexander O. (COO and Secretary) Sale 2,500 20.18 50,450
2018-12-03 Ho Carole (Chief Medical Officer) Sale 17,500 18.80 328,930
2018-12-03 Watts Ryan J. (President and CEO) Sale 18,333 18.79 344,458
2018-11-15 Ho Carole (Chief Medical Officer) Sale 17,500 18.07 316,155
2018-11-15 Watts Ryan J. (President and CEO) Sale 13,588 18.12 246,241
2018-11-13 Watts Ryan J. (President and CEO) Sale 4,746 18.00 85,428
2018-10-02 Schuth Alexander O. (COO and Secretary) Option Ex 7,043 7.44 52,399
2018-10-01 Ho Carole (Chief Medical Officer) Sale 17,500 21.72 380,100
2018-10-01 Watts Ryan J. (President and CEO) Sale 18,333 21.72 398,192
2018-09-04 Ho Carole (Chief Medical Officer) Sale 17,500 19.05 333,375
2018-09-04 Watts Ryan J. (President and CEO) Sale 18,333 19.06 349,426
2018-08-29 Ho Carole (Chief Medical Officer) Sale 17,500 18.04 315,700
2018-08-29 Watts Ryan J. (President and CEO) Sale 18,334 18.05 330,928
2018-06-22 Schuth Alexander O. (COO and Secretary) Option Ex 5,918 5.28 31,247
2017-12-12 Crestline Management, Lp (10% Owner) Buy 275,000 18.00 4,950,000

Insider trading activities including stock purchases, stock sales, and option exercises of DNLI listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Denali Therapeutics Inc. (symbol DNLI, CIK number 1714899) see the Securities and Exchange Commission (SEC) website.